Targeted Therapy and Immunotherapy for Advanced Malignant Conjunctival Tumors: Systematic Review

*Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, MI, U.S.A.

†Department of Ophthalmology, University of Health Sciences, Ulucanlar Eye Training and Research Hospital, Ankara, Turkiye

‡Department of Ophthalmology, Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand

§Division of Hematology-Oncology, Department of Internal Medicine, Roger Cancer Center, University of Michigan, Ann Arbor, Michigan, U.S.A.

Accepted for publication July 5, 2023.

Supported by Richard N and Marilyn K Witham Professorship. It has no effect on the design, conduct, and result of the study.

The authors have no financial or conflicts of interest to disclose.

Address correspondence and reprint requests to Hakan Demirci, M.D., Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, 1000 Wall St, Ann Arbor, MI 48105. E-mail:[email protected]

留言 (0)

沒有登入
gif